INBXV

Inhibrx, Inc. Ex-distribution When-Issued$30.85

%

Analyst Rating:N/A

Analyst Rating: N/A

Stock Details

CEO

Mark Paul Lappe

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

166

Address

N/A

No description available.

Income Statement

Revenue

Net Income

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Inhibrx, Inc. Ex-distribution When-Issued $30.85

EPS

Revenue

Congress Tracker

Insider Trading of Key Employees

Financial News: INBXV